Get the Stockscreener App
5.33
7.03%
0.35
After Hours:
5.30
-0.03
-0.56%
Cingulate Inc stock is traded at $5.33, with a volume of 338.97K.
It is up +7.03% in the last 24 hours and down -14.03% over the past month.
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
See More
Previous Close:
$4.98
Open:
$5.1
24h Volume:
338.97K
Relative Volume:
0.68
Market Cap:
$65.30M
Revenue:
-
Net Income/Loss:
$-22.21M
P/E Ratio:
-1.2251
EPS:
-4.3505
Net Cash Flow:
$-17.41M
1W Performance:
+13.16%
1M Performance:
-14.03%
6M Performance:
+44.84%
1Y Performance:
+31.60%
1-Day Range:
$5.06
$5.40
1-Week Range:
$4.76
$5.54
52-Week Range:
$3.20
$11.89
Cingulate Inc Stock (CING) Company Profile
Name
Cingulate Inc
Sector
Industry
Phone
(913) 942-2300
Address
1901 W. 47TH PLACE, KANSAS CITY
Compare CING vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
5.33 | 61.01M | 0 | -22.21M | -17.41M | -4.3505 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | ROTH MKM | Buy |
| Dec-22-23 | Downgrade | Laidlaw | Buy → Hold |
Cingulate Inc Stock (CING) Latest News
At least five PDUFA dates on FDA’s May docket - biocentury.com
FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate - BioSpace
CING Should I Buy - Intellectia AI
Cingulate Inc. (NASDAQ:CING) Short Interest Up 31.7% in April - MarketBeat
What's going on with Cingulate stock today? - MSN
Why did Cingulate stock skyrocket today? - MSN
Cingulate Inc. (NASDAQ: CING) registers 4.21M common shares for resale - Stock Titan
[EFFECT] Cingulate Inc. SEC Filing - Stock Titan
Here is Why Cingulate (CING) is One of the Best NASDAQ Growth Stocks to Buy and Hold Forever - Insider Monkey
CING Options Volatility — NASDAQ:CING - TradingView
CING Options Chain — NASDAQ:CING - TradingView
Should I buy or sell Cingulate (CING) stock today | Q4 2025: Earnings Fall ShortShared Momentum Picks - Xã Châu Thành
CING (Cingulate Inc.) shares fall 2.8% after Q4 2025 EPS misses analyst estimates by a wide margin.Dividend Report - Xã Châu Thành
Cingulate Inc (CING) Sees New Options Listings for April 22nd - GuruFocus
CING SEC FilingsCingulate Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cingulate (CING) Stock: Why Automation Investment (+8.72%) 2026-04-20Analyst Upgrade - Xã Vĩnh Công
Q1 EPS Estimates for Cingulate Increased by Analyst - MarketBeat
Cingulate Inc. (NASDAQ: CING) registers 4.21M resale shares; Falcon Creek holds 3.86M - Stock Titan
Research Analysts Issue Forecasts for Cingulate Q1 Earnings - MarketBeat
Quarterly Risk: Can Cingulate Inc Equity Warrant maintain its current growth rateEarnings Recap Report & Safe Capital Allocation Plans - baoquankhu1.vn
Short Interest in Cingulate Inc. (NASDAQ:CING) Rises By 106.8% - MarketBeat
Is Cingulate (CING) Stock exposed to global risks | Price at $5.84, Down 2.01%Stock Trading Network - Cổng thông tin điện tử tỉnh Lào Cai
Amazon To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm
Market Fear: Is Cingulate Inc likely to announce a buybackTrade Entry Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Ascendiant Capital Markets Has Lowered Expectations for Cingulate (NASDAQ:CING) Stock Price - MarketBeat
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Nasdaq
Energy Moves: Is Cingulate Inc likely to announce a buyback2026 Price Action Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Is Cingulate (CING) Stock Moving Higher | Price at $6.20, Up 0.98%Professional Trade Ideas - UBND thành phố Hải Phòng
Cingulate Adds Independent Director Jiang to Board Committees - The Globe and Mail
CINGW Stock Analysis: Cingulate Inc. Warrants 2.59% dip at $0.03 performance outlook - Cổng thông tin điện tử tỉnh Tây Ninh
Cingulate appoints Zhanpeng Jiang to board of directors and key committees - Investing.com Australia
Cingulate Appoints Zhanpeng Jiang to Board of Directors - National Today
Cingulate appoints Zhanpeng Jiang to board of directors and key committees By Investing.com - Investing.com South Africa
Zhanpeng Jiang joins Cingulate (CING) board with option for 15,000 shares - Stock Titan
Revenue Check: Can Cingulate Inc Equity Warrant sustain earnings growth2026 Chart Watch & Accurate Buy Signal Notifications - baoquankhu1.vn
Revenue Check: Is Cingulate Inc Equity Warrants ROE strong enough2026 Sector Review & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Earnings Miss: Can Cingulate Inc Equity Warrant maintain its current growth rate2026 AllTime Highs & Weekly Setup with High ROI Potential - baoquankhu1.vn
Cingulate stock jumps overnight: US Patent Office clears ADHD drug filing ahead of May FDA catalyst - MSN
What's Going On With Cingulate Stock Today? - Dailyhunt
Cingulate (CING) registers 3.5M shares for Lincoln Park under $25M equity line - stocktitan.net
Falcon Creek discloses 28.5% Cingulate (CING) ownership stake - Stock Titan
Wall Street Recap: What is the target price for Cingulate Inc Equity Warrant stockMarket Trend Summary & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
FOMO Trade: Is Cingulate Inc currently under institutional pressureMarket Trend Report & Smart Money Movement Tracker - baoquankhu1.vn
Cingulate Announces ATM Equity Program and Share Issuance - The Globe and Mail
Cingulate Inc. Enters ATM Sales Agreement with A.G.P./Alliance Global Partners for Common Stock Offering – March 2026 - Minichart
Can Cingulate Inc Equity Warrant sustain earnings growthWeekly Trade Review & Trade Opportunity Analysis - baoquankhu1.vn
Cingulate Inc Stock (CING) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):